GUTS Q4 2023 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7,000

Gross Profit

$5,00071.4% margin

Operating Income

-$13M-185442.9% margin

Net Income

-$19M-274000.0% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-80.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$76M

Total Liabilities

$401M

Stockholders' Equity

-$325M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7,000	$0	—
Gross Profit	$5,000	$0	—
Operating Income	-$13M	-$11M	-13.7%
Net Income	-$19M	-$11M	-76.6%